qXR-CTR vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Qure.ai
VS

AI Verdict

Tool A is an AI-powered software for analyzing chest X-rays to assess heart size and potential heart failure risk. Tool B is an AI-powered insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias. While both utilize AI in cardiology, they are not direct competitors as they address different diagnostic modalities and clinical questions: imaging analysis for structural assessment versus implantable device monitoring for rhythm disorders.

Choose qXR-CTR if…

Choose qXR-CTR if your primary need is rapid, automated assessment of heart size and initial heart failure risk from standard chest X-ray images. This tool is ideal for integrating into radiology workflows to provide an objective, AI-driven measurement of the cardiothoracic ratio, aiding in early identification of potential cardiac abnormalities.

View qXR-CTR →

Choose LINQ II Insertable Cardiac Monitor if…

Choose LINQ II Insertable Cardiac Monitor if you require long-term, continuous monitoring of heart rhythms to diagnose infrequent or asymptomatic arrhythmias over an extended period. This device is best suited for patients experiencing unexplained syncope, palpitations, or cryptogenic stroke where a transient arrhythmia is suspected but difficult to capture with conventional monitoring methods.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature qXR-CTR LINQ II Insertable Cardiac Monitor
Deployment Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

While qXR-CTR offers a streamlined workflow for radiologists by automating a specific measurement from X-rays, LINQ II provides a more comprehensive and flexible usability experience for both patients and clinicians. Its remote programming capabilities and patient-friendly mobile app significantly reduce the burden of in-person visits and allow for continuous, unobtrusive monitoring, enhancing long-term usability and patient convenience.

Clinical Value

LINQ II Insertable Cardiac Monitor

While qXR-CTR offers valuable automated assessment for heart failure risk from X-rays, LINQ II provides a more profound and continuous clinical impact. Its long-term, AI-enhanced monitoring for arrhythmias, significant reduction in false alerts, and proven cost-effectiveness in stroke prevention, coupled with its pediatric indication, offer a broader and more critical diagnostic and management solution for complex cardiac conditions.

Pricing & Value

LINQ II Insertable Cardiac Monitor

Both tools have undisclosed, enterprise-negotiated pricing. However, LINQ II distinguishes itself by having published cost-effectiveness data, demonstrating its value in reducing strokes and improving quality-adjusted life years, with a favorable incremental cost-effectiveness ratio. This transparency in demonstrating economic value provides a clearer understanding of its return on investment for healthcare systems, despite the lack of public pricing.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

While both tools meet compliance and deployment requirements, Medtronic's (Tool B) long-standing global presence, vast customer base of over 1 million patients, and extensive strategic partnerships with major healthcare providers like GE HealthCare and Philips demonstrate a significantly higher level of proven enterprise readiness and established infrastructure compared to Qure.ai.

Innovation

LINQ II Insertable Cardiac Monitor

While qXR-CTR demonstrates innovation in applying AI to automate X-ray analysis, LINQ II showcases a higher degree of innovation through its combination of an insertable device with advanced AI algorithms for enhanced accuracy and false alert reduction, remote programming, and extended longevity. Furthermore, its use of wafer-scale manufacturing, a novel approach in medical devices, positions it for future advancements and capabilities.

Support & Docs

LINQ II Insertable Cardiac Monitor

While Qure.ai (Tool A) offers transparent and responsive support channels with a dedicated client success partner and 24/7 availability, Medtronic (Tool B) provides a more comprehensive and established support ecosystem. Medtronic's extensive resources include dedicated technical and patient service lines, detailed device manuals, patient education materials (app guides, brochures, videos), and a clinician-focused educational platform (Medtronic Academy), reflecting a broader and more mature support infrastructure for a complex medical device.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature qXR-CTR LINQ II Insertable Cardiac Monitor
Name qXR-CTR LINQ II Insertable Cardiac Monitor
Company Qure.ai Technologies Medtronic
Description (Core Function) AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images. Advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring.
Tagline AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment. Advanced insertable cardiac monitoring with AI-powered accuracy and remote management.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Radiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring qXR-CTR and LINQ II Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

qXR-CTR is an AI-powered software that automates cardiothoracic ratio (CTR) measurement from chest X-rays, designed to integrate into existing radiology workflows to assist physicians in diagnosing and monitoring heart conditions, particularly for initial heart size assessment and potential heart failure risk. LINQ II, an insertable cardiac monitor, provides long-term, continuous heart rhythm monitoring for diagnosing arrhythmias, integrating into cardiology workflows involving device implantation, remote programming, and patient data transmission via mobile app or home communicator.
qXR-CTR utilizes deep learning algorithms to automate the precise measurement of the cardiothoracic ratio from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. LINQ II features AccuRhythm AI algorithms for enhanced accuracy in long-term, continuous heart rhythm monitoring, specifically designed to reduce false alerts for atrial fibrillation and pause while preserving true alerts, and includes an innovative PVC detection algorithm.
qXR-CTR provides annotated X-rays and structured reports in DICOM and JSON formats, integrating seamlessly into existing radiology workflows. The LINQ II system explicitly offers 'data export: yes' and facilitates data transmission to the CareLink network via the MyCareLink Heart mobile app or MyCareLink Relay home communicator, with remote programming capabilities that may reduce office visits.
qXR-CTR is suited for Cardiology and Radiology, aiding in the assessment of heart size from chest X-rays for adults aged 22 years and older, and can jointly screen for increased CTR and pleural effusion as markers for heart failure. LINQ II is specifically for Cardiology, providing long-term arrhythmia diagnosis for adult patients and has a pediatric indication for ages 2 and up, for those experiencing infrequent symptoms like dizziness, palpitations, syncope, and chest pain.
qXR-CTR involves software interpretation for automated measurements from existing imaging, integrating into standard radiology workflows. LINQ II requires understanding of an insertable device, its implantation workflow, remote programming capabilities, and the use of the MyCareLink Heart app or MyCareLink Relay home communicator for continuous monitoring and data review, with educational resources available for insertion and follow-up.
For qXR-CTR, the provided information does not explicitly detail customer references or multi-site rollout case studies, though it is clinically validated in multiple geographies and integrates into existing standard of care workflows. For LINQ II, Medtronic states that 'More than 1 million patients have received a Medtronic ICM worldwide,' indicating extensive real-world use and suggesting scalability for various practice sizes, from solo to large health systems.
AI Tool Finder
AI-powered search. Results may not be comprehensive.